Inventor · disambiguated record
Lin Wang
Also filed as: WANG I LIN · WANG LIN · WANG LIN-FA
9 granted patents·7 pending applications·88 citations·filing 1989–2025
84Inventor score
Top patents by PatentIndex Score
16 records- 0188US7553653B2Variants and chemically-modified variants of phenylalanine ammonia-lyaseBIOMARIN PHARM INC·Filed 2005·Granted Jun 30, 2009·34 cites·7 claims
- 0284US2025353870A1Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 0382US11530234B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Dec 20, 2022·1 cites·21 claims
- 0480US10883091B2DNA polymerase variant and application thereofMGI TECH CO LTD·Filed 2019·Granted Jan 5, 2021·1 cites·12 claims
- 0579US12312378B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 0678US5585253AExtracellular serine protease and a Bacillus subtilis alkaline neutral an serine protease mutant strainUNIV CALIFORNIA·Filed 1989·Granted Dec 17, 1996·50 cites·33 claims
- 0776US10881681B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jan 5, 2021·2 cites·21 claims
- 0869US2022265779A1Enhancement of skeletal muscle stem cell engraftment by dual delivery of vegf and igf-1HARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 0967US2025179445A1Recombinant kod polymeraseBGI SHENZHEN·Filed 2024·Application pending·0 cites
- 1062US11591358B2Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Feb 28, 2023·0 cites·15 claims
- 1154US2017232074A1Enhancement of skeletal muscle stem cell engraftment by dual delivery of vegf and igf-1HARVARD COLLEGE·Filed 2017·Application pending·0 cites
- 1252US2024398896A1Inflammasome inhibitionNAT UNIV SINGAPORE·Filed 2022·Application pending·0 cites
- 1347US12168785B2Recombinant KOD polymeraseBGI SHENZHEN·Filed 2018·Granted Dec 17, 2024·0 cites·12 claims
- 1446US2023211007A1Antibody mutant and application thereofUNIV SHENYANG PHARMACEUTICAL·Filed 2020·Application pending·0 cites
- 1545US2010324067A1Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activitiesLIU GANG·Filed 2007·Application pending·0 cites
- 1643US11718636B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Aug 8, 2023·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →